Received Mar 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | 5 | U8524DA | IM / RA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 52F7M | IM / LA |
Patient has Neuromyelitis Optica Spectrum Disorder that is well managed at this time and at the time of vaccine. Patient states that he soon started experiencing weakness in both legs and had 2 serious falls r/t the weakness. Patient states that he spoke with his neurologist at that time and has a follow-up appointment in 1 week. Patient states that he returned to baseline after 2 weeks.
Neuromyelitis Optica Spectrum Disorder
Unknown
Unknown